Nanopore tRNAment - Deciphering tRNA modification landscapes and networks

At a glance

Project duration
06/2026  – 05/2029
DFG classification of subject areas

General Genetics and Functional Genome Biology

Biology

Biochemistry

Basic Research in Biology and Medicine

Funded by

DFG Individual Research Grant DFG Individual Research Grant

Project description

Transfer RNAs (tRNAs) play a central role in protein translation by decoding mRNA codons and delivering corresponding amino acids to the ribosome. Their function relies heavily on chemical modifications, which influence tRNA folding, stability, aminoacylation, and codon–anticodon recognition. Over 150 modifications have been identified, with each tRNA typically modified at 5–15 positions. These modifications vary in complexity—from simple chemical changes (e.g., methylation, deamination) to elaborate enzymatic pathways (e.g., queuosine, mcm5S2U). Most are evolutionarily conserved, underscoring their importance for living organisms. Diseases caused by defective tRNA modification are called “tRNA modopathies”. Studying tRNA modifications and the enzymes responsible for them is vital for understanding “tRNA modopathies”. To date, 54 such enzymes and their partners have been linked to human diseases, including neurological disorders, kidney dysfunction, mitochondrial diseases, and cancer. For example, mitochondrial tRNA mutations contribute to MELAS and MERRF syndromes. Mutations in NSUN2, a tRNA methyltransferase for m⁵C, cause intellectual disability and microcephaly. Additionally, modified suppressor tRNAs hold therapeutic potential for correcting pathogenic nonsense mutations. Thus, tRNA modification profiling is critical for understanding and treating various human diseases. The goal of this project is to obtain a tRNA transcriptome-wide view of the tRNA modification landscape in the experimental organisms Schizosaccharomyces pombe and in human cells HCT116 and hIPSC. Methodologically, we will obtain this information by performing direct RNA sequencing of tRNAs ex cellulo using Oxford Nanopore Technology (ONT). Given the relatively small size of the S. pombe genome, studies in yeast provide an effective platform for investigating tRNA modifications, serving here as a testbed for approaches that will be extended to human cells, a strategy that has proven successful across many areas of genetics and molecular biology.

Sustainable Development Goals (United Nations)

Good Health and Well-being